Molecular dynamics study on the inhibition mechanisms of ReACp53 peptide for p53–R175H mutant aggregation
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
p53 mutant aggregation can lead to loss-of-function (LoF), dominant-negative (DN) and gain-of-function (GoF) effects, involved in tumor growth.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The results show that ReACp53 has hydrophobic interactions with residues Leu188 and Leu201 and forms salt bridges or hydrogen bonds with residues Asp186, Glu198, Asp204, Glu 221 and Glu 224, which prevent the aggregation-prone region (residues 182–213) from being exposed.”
From Targeting p53 pathways: mechanisms, structures, and advances in therapy (2023) · cites this paper as [491]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The IARC TP53 database: new online mutation analysis and recommendations to users
Olivier, M., Eeles, R., Hollstein, M., Khan, M. A., Harris, C. C., & Hainaut, P. (2002) · Human Mutation · doi:10.1002/humu.10081 · Cited by 1,248
PRIMA-1 reactivates mutant p53 by covalent binding to the core domain
Lambert, J. M. R., Gorzov, P., Veprintsev, D. B., Söderqvist, M., Segerbäck, D., Bergman, J., Fersht, A. R., Hainaut, P., Wiman, K. G., & Bykov, V. J. N. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.03.003 · Cited by 592
Therapeutic targeting of p53: all mutants are equal, but some mutants are more equal than others
Sabapathy, K., & Lane, D. P. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.151 · Cited by 517
A Designed Inhibitor of p53 Aggregation Rescues p53 Tumor Suppression in Ovarian Carcinomas
Soragni, A., Janzen, D. M., Johnson, L. M., Lindgren, A. G., Thai-Quynh Nguyen, A., Tiourin, E., Soriaga, A. B., Lu, J., Jiang, L., Faull, K. F., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2015.12.002 · Cited by 341
Solution structure of p53 core domain: Structural basis for its instability
Cañadillas, J. M. P., Tidow, H., Freund, S. M. V., Rutherford, T. J., Ang, H. C., & Fersht, A. R. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510941103 · Cited by 174
Research works printed but not linked: 65
- Wei, 2010, Phys. Chem. Chem. Phys., 12, 3622, 10.1039/c000755m · DOI
- Nussbaum, 2013, Prion, 7, 14, 10.4161/pri.22118 · DOI · Paper page
- Dikiy, 2012, Biochim. Biophys. Acta, 1818, 1013, 10.1016/j.bbamem.2011.09.008 · DOI · Paper page
- Patel, 2014, J. Phys. Chem. Lett., 5, 1864, 10.1021/jz5001775 · DOI
- Cao, 2013, Curr. Opin. Struct. Biol., 23, 82, 10.1016/j.sbi.2012.11.003 · DOI · Paper page
- Gong, 2015, Curr. Protein Pept. Sci., 16, 135, 10.2174/1389203715666141128115649 · doi:10.2174/1389203715666141128115649
- Lasagna-Reeves, 2013, Biochem. Biophys. Res. Commun., 430, 963, 10.1016/j.bbrc.2012.11.130 · DOI
- Bossi, 2007, Head Neck, 29, 272, 10.1002/hed.20529 · DOI · Paper page
- Riley, 2008, Nat. Rev. Mol. Cell Biol., 9, 402, 10.1038/nrm2395 · DOI · Paper page
- Vogelstein, 2000, Nature, 408, 307, 10.1038/35042675 · DOI · Paper page
- Vousden, 2009, Cell, 137, 413, 10.1016/j.cell.2009.04.037 · DOI · Paper page
- Ang, 2006, J. Biol. Chem., 281, 21934, 10.1074/jbc.M604209200 · DOI · Paper page
- Silva, 2013, Biosci. Rep., 33, e00054, 10.1042/BSR20130065 · DOI · Paper page
- Silva, 2018, Acc. Chem. Res., 51, 181, 10.1021/acs.accounts.7b00473 · DOI · Paper page
- Freed-Pastor, 2012, Genes Dev., 26, 1268, 10.1101/gad.190678.112 · DOI · Paper page
- Joerger, 2004, J. Biol. Chem., 279, 1291, 10.1074/jbc.M309732200 · DOI · Paper page
- Friedler, 2002, Proc. Natl. Acad. Sci. U. S. A., 99, 937, 10.1073/pnas.241629998 · DOI · Paper page
- He, 2019, Proc. Natl. Acad. Sci. U. S. A., 116, 8859, 10.1073/pnas.1903077116 · DOI · Paper page
- Bullock, 2001, Nat. Rev. Cancer, 1, 68, 10.1038/35094077 · DOI · Paper page
- Li, 2020, Phys. Chem. Chem. Phys., 22, 9225, 10.1039/C9CP06671C · DOI
- Rangel, 2014, Prion, 8, 75, 10.4161/pri.27776 · DOI · Paper page
- Xu, 2011, Nat. Chem. Biol., 7, 285, 10.1038/nchembio.546 · DOI · Paper page
- Higashimoto, 2006, Biochemistry, 45, 1608, 10.1021/bi051192j · DOI · Paper page
- Ishimaru, 2003, Biochemistry, 42, 9022, 10.1021/bi034218k · DOI · Paper page
- Lee, 2003, J. Mol. Biol., 327, 699, 10.1016/S0022-2836(03)00175-X · DOI
- Rigacci, 2008, Biophys. J., 94, 3635, 10.1529/biophysj.107.122283 · DOI
- Costa, 2016, Cold Spring Harbor Perspect. Biol., 8, e00054, 10.1101/cshperspect.a023614 · DOI · Paper page
- Wang, 2015, Proc. Natl. Acad. Sci. U. S. A., 112, 2443, 10.1073/pnas.1500262112 · DOI · Paper page
- Lei, 2016, Phys. Chem. Chem. Phys., 18, 8098, 10.1039/C5CP06538K · DOI
- Ano Bom, 2012, J. Biol. Chem., 287, 28152, 10.1074/jbc.M112.340638 · DOI · Paper page
- Strano, 2001, FEBS Lett., 490, 163, 10.1016/S0014-5793(01)02119-6 · DOI · Paper page
- Strano, 2002, J. Biol. Chem., 277, 18817, 10.1074/jbc.M201405200 · DOI · Paper page
- Milner, 1991, Cell, 65, 765, 10.1016/0092-8674(91)90384-B · DOI · Paper page
- Chan, 2004, Mol. Cell. Biol., 24, 3536, 10.1128/MCB.24.8.3536-3551.2004 · DOI · Paper page
- Silva, 2014, Trends Biochem. Sci., 39, 260, 10.1016/j.tibs.2014.04.001 · DOI · Paper page
- Kanapathipillai, 2018, Cancers, 10, 154, 10.3390/cancers10060154 · DOI · Paper page
- Blandino, 2018, J. Exp. Clin. Cancer Res., 37, 30, 10.1186/s13046-018-0705-7 · DOI · Paper page
- Loh, 2020, Biomolecules, 10, 303, 10.3390/biom10020303 · DOI · Paper page
- Rangel, 2014, FASEB J., 28, 754.4, 10.1096/fasebj.28.1_supplement.754.4 · doi:10.1096/fasebj.28.1_supplement.754.4
- Chen, 2021, Cancer Cell, 39, 225, 10.1016/j.ccell.2020.11.013 · DOI · Paper page
- Chen, 2017, Biochem. Biophys. Res. Commun., 489, 130, 10.1016/j.bbrc.2017.05.111 · DOI
- Zhang, 2020, Prostate Cancer Prostatic Dis., 23, 160, 10.1038/s41391-019-0172-z · DOI · Paper page
- Wang, 2017, Proc. Natl. Acad. Sci. U. S. A., 114, e2634, 10.1073/pnas.1700308114 · DOI · Paper page
- Bullock, 2001, Nat. Rev. Cancer, 1, 68, 10.1038/35094077 · DOI · Paper page
- Liu, 2013, Nucleic Acids Res., 41, 6034, 10.1093/nar/gkt305 · DOI · Paper page
- Khoo, 2014, Nat. Rev. Drug Discovery, 13, 217, 10.1038/nrd4236 · DOI · Paper page
- Pedrote, 2018, J. Biol. Chem., 293, 11374, 10.1074/jbc.RA118.003285 · DOI · Paper page
- Pradhan, 2019, Nucleic Acids Res., 47, 1637, 10.1093/nar/gky1314 · DOI · Paper page
- Liao, 2013, Chem. Cent. J., 7, 44, 10.1186/1752-153X-7-44 · DOI · Paper page
- Peters, 2010, J. Chem. Theory Comput., 6, 2935, 10.1021/ct1002626 · DOI · Paper page
- Lindorff-Larsen, 2010, Proteins, 78, 1950, 10.1002/prot.22711 · DOI · Paper page
- Cino, 2016, Sci. Rep., 6, 32535, 10.1038/srep32535 · DOI · Paper page
- Nosé, 1983, Mol. Phys., 50, 1055, 10.1080/00268978300102851 · DOI · Paper page
- Bussi, 2007, J. Chem. Phys., 126, 014101, 10.1063/1.2408420 · DOI · Paper page
- Darden, 1993, J. Chem. Phys., 98, 10089, 10.1063/1.464397 · DOI · Paper page
- Miyamoto, 1992, J. Comput. Chem., 13, 952, 10.1002/jcc.540130805 · DOI · Paper page
- Hess, 2009, J. Comput. Chem., 18, 1463, 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H · DOI · Paper page
- Kabsch, 1983, Biopolymers, 22, 2577, 10.1002/bip.360221211 · DOI · Paper page
- Day, 2002, J. Mol. Biol., 322, 189, 10.1016/S0022-2836(02)00672-1 · DOI · Paper page
- Jin, 2019, Phys. Chem. Chem. Phys., 21, 10981, 10.1039/C9CP01803D · DOI
- Zhan, 2021, Chem. Commun., 57, 4267, 10.1039/D1CC00404B · DOI
- Lei, 2019, FASEB J., 33, 4225, 10.1096/fj.201801973R · DOI
- Luo, 2002, J. Comput. Chem., 23, 1244, 10.1002/jcc.10120 · DOI · Paper page
- Reumers, 2009, Hum. Mutat., 30, 431, 10.1002/humu.20905 · DOI · Paper page
- Li, 2019, Phys. Chem. Chem. Phys., 21, 15686, 10.1039/C9CP02561H · DOI
Cited by
Targeting p53 pathways: mechanisms, structures, and advances in therapy
Wang, H., Guo, M., Wei, H., & Chen, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01347-1 · Cited by 1,016
“5 Most TP53 mutations are missense mutations located in the DBD. 3,4,203,205,380 p53 mutants mainly affect the thermostability of p53 protein, structural stability (structural mutants such as 175, 220, 245 and 249) or p53-DNA contact (DNA contact mutants such as 248 and 273).”
BackgroundInfluential
Metadata
- Authors
- Lei, J., Cai, M., Shen, Y., Lin, D., & Deng, X.
- Affiliations
- Institute of Space Science and Technology, Nanchang University, Xuefu Avenue 999, Nanchang City 330031, China
- Department of Physics, School of Sciences, Nanchang University, Xuefu Avenue 999, Nanchang City 330031, China
- Department of Physics and Qian Xuesen Collaborative Research Center of Astrochemistry and Space Life Sciences, Ningbo University, Ningbo, Zhejiang City 315211, China
- Venue
- Physical Chemistry Chemical Physics
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2021
- Volume
- 23
- Issue
- 40
- Pages
- 23032-23041
- ISSN
- 1463-9076
- 1463-9084
- Cited by
- 16
- References
- 5
- Language
- en
- Funders
- National Natural Science Foundation of China (11904152, 11804174)
- Nanchang University (9140-06301493)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.